Episode notes
We discuss the latest news leak from the DEA regarding the rescheduling of Cannabis from an S1 to S3 drug. This news opens up a wealth of opportunities for the industry. Pablo and Charlie navigate the news and dissect the good and potential hurdles that arise with this rescheduling event.
Follow us on
Keywords
Cannabis
Rescheduling
Investing
C Suite
Marijuana
dispensary
Dispensaries
DEA
280E
MSOs
Schedule 3
HHS
schedule III
Canada
Meme Stock
Florida
Germany
Pharmacy
Clinics
medical cannabis
europe
Ohio
recreational cannabis
vape
vaping
vapes
schedule 1
Zuanic & associates
Pablo Zuanic
Cresco labs
HSA
Investing Cannabis
Charlie Bachtell